Prosecution Insights
Last updated: October 27, 2026

Holly Michaela Kipouros, USPTO Patent Examiner

Listed by the USPTO as KIPOUROS, HOLLY MICHAELA

Tech Center 2800 • Art Units: 1631 1632 1759 1798 1799 2855

This examiner grants 70% of resolved cases

Analysis

Holly Michaela Kipouros is assigned to Tech Center 2800 and Art Unit 1631. Her record includes 540 resolved cases, a 69.8% allowance rate, and a median of 1,084 days to allowance. The interview lift is 21.3%, showing a positive association between interviews and allowance in the supplied data.

The listed companies are Bristol-Myers Squibb Company, The Procter & Gamble Company, and The Board of Trustees of the Leland Stanford Junior University. The listed firms are Meunier Carlin & Curfman LLC, Acuity Law Group, P.C., and Alleman Hall LLP. The interview result gives practitioners a reason to consider examiner contact as part of prosecution planning. The 69.8% allowance rate and 1,084-day median should be evaluated together when counseling clients about outcome prospects and timing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

69.8%
Allow Rate
+1.8% vs TC avg
576
Total Applications
+21.3%
Interview Lift
1084
Avg Prosecution Days
Based on 540 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
19.9%
§102 Novelty
49.9%
§103 Obviousness
24.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18693731 METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLUTION COMPRISING A RECOMBINANT PROTEIN IN A STORAGE CONTAINER Non-Final OA BRISTOL-MYERS SQUIBB COMPANY
18739491 FABRIC TREATMENT Non-Final OA The Procter & Gamble Company
17920541 MICROFLUIDIC CHIPS AND MICROPHYSIOLOGICAL SYSTEMS USING THE SAME Final Rejection The Board of Trustees of the Leland Stanford Junior University
18590569 ROLLED CELL CULTURE SUBSTRATES FOR FIXED BED BIOREACTORS WITH CONTROLLED PERFUSION ZONES Non-Final OA CORNING INCORPORATED
18714512 MULTI-TARGETED, MODULAR VIRUS SENSING PLATFORM Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18014726 HERMETICALLY OR ASEPTICALLY SEALED BIOREACTOR SYSTEM AND RELATED METHOD THEREOF Final Rejection University of Virginia Patent Foundation
18476536 Cover For Cell Culture Apparatus Non-Final OA NOVOCURE GMBH
18034559 USE OF LIPOXYGENASE Non-Final OA Novozymes A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Holly Michaela Kipouros's allowance rate?

69.8% of resolved applications examined by Holly Michaela Kipouros were allowed (540 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.

Does an interview help with examiner Holly Michaela Kipouros?

This examiner's interview lift is +21.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Holly Michaela Kipouros take to allow a patent?

Applications allowed by Holly Michaela Kipouros took 1,084 days on average from filing to allowance.

Which art unit does examiner Holly Michaela Kipouros work in?

Holly Michaela Kipouros examines applications in Art Unit 1631 in Tech Center 2800 (Semiconductors, Circuits & Optics).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month